Bioventus Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Bioventus Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Bioventus Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $46M, a 1714% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $46M +$43.5M +1714% Dec 31, 2023 10-K 2024-03-12
Q4 2022 $2.54M +$216K +9.31% Dec 31, 2022 10-K 2024-03-12
Q4 2021 $2.32M -$673K -22.5% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $2.99M Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.